Author
The author is Chair Of The Board Of Directors at International Alliance of Patients' Organizations (IAPO) and CEO, DakshamAHealth
In the Indian context, this is even more important as burden of care most often falls on the patient and for the government to have a publicly funded cancer care program, value assessment will enable to make the right choices for domestic innovation and generic medicines.
Read More
